Research Paper A short deletion in the DNA-binding domain of STAT3 suppresses and of colon cancer cells

被引:0
|
作者
Xiong, Yi-Jia [1 ]
Liu, Dong-Yang [2 ]
Shen, Rong-Rong [3 ]
Xiong, Yong [3 ]
机构
[1] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China
[2] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gen Surg, Shanghai 200233, Peoples R China
[3] Shanghai Univ Med & Hlth Sci, Dept Gen Surg, Shanghai Peoples Hosp East 6, Shanghai 201308, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 04期
关键词
STAT3; gain of function; JAK/STAT pathway; colon cancer; COLORECTAL-CANCER; AXIS;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, we investigated the effect of a short deletion in the DNA-binding domain of STAT3 (STAT3(del)) on the transcriptional activation of STAT3 target genes and its relationship with colon carcinogenesis. We used the CRISPR-CAS9 gene editing system to delete a short sequence encoding amino acids 400-411 in the DNA-binding domain (amino acid sequence: 317-567) from STAT3 gene in SW480, SW620 and HCT116 colon cancer cells. ChIP sequencing analysis showed that STAT3(del) occupancy was significantly reduced in 1029 genes and significantly increased in 475 genes compared to wild-type STAT3. The mutation altered the DNA motifs recognized by STAT3(del) as compared to the wild-type STAT3. We observed a strong correlation between expression of the STAT3 target genes and the loss or gain of STAT3(del) binding to their promoters. CCK-8, wound healing, and TUNEL assays showed reduced proliferation, migration, and survival of SW480, SW620 and HCT-116 cells expressing STAT3(del) as compared to the corresponding controls. These findings demonstrate that a short deletion in the DNA-binding domain of STAT3 alters its genome-wide DNA-binding and transcriptional profile of STAT3-target proteins, and suppresses the growth, progression and survival of colon cancer cells.
引用
收藏
页码:5185 / 5196
页数:12
相关论文
共 50 条
  • [1] Drugging the "undruggable" DNA-binding domain of STAT3
    Zhang, Jian-Ting
    Liu, Jing-Yuan
    ONCOTARGET, 2016, 7 (41) : 66324 - 66325
  • [2] MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain
    Son, Dong Ju
    Zheng, Jie
    Jung, Yu Yeon
    Hwang, Chul Ju
    Lee, Hee Pom
    Woo, Ju Rang
    Baek, Song Yi
    Ham, Young Wan
    Kang, Min Woong
    Shong, Minho
    Kweon, Gi Ryang
    Song, Min Jong
    Jung, Jae Kyung
    Han, Sang-Bae
    Kim, Bo Yeon
    Yoon, Do Young
    Choi, Bu Young
    Hong, Jin Tae
    THERANOSTICS, 2017, 7 (18): : 4632 - 4642
  • [3] Drugging the "undrugable" DNA-binding domain of STAT3 for inhibition of cancer cell migration and invasion
    Huang, Wei
    Zhang, Jian-Ting
    CANCER RESEARCH, 2012, 72
  • [4] Rutaecarpine suppresses the proliferation and metastasis of colon cancer cells by regulating the STAT3 signaling
    Chan, Shixin
    Sun, Rui
    Tu, Xucan
    Guo, Manyu
    Yuan, Qianqian
    Yu, Zhen
    Wang, Zhenglin
    Hong, Shaocheng
    Han, Wei
    Zou, Bingbing
    Li, Zeng
    Zhang, Huabing
    Chen, Wei
    JOURNAL OF CANCER, 2022, 13 (03): : 847 - 857
  • [5] A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion
    Huang, Wei
    Dong, Zizheng
    Wang, Fang
    Peng, Hui
    Liu, Jing-Yuan
    Zhang, Jian-Ting
    ACS CHEMICAL BIOLOGY, 2014, 9 (05) : 1188 - 1196
  • [6] JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells
    Nishimoto, Arata
    Kugimiya, Naruji
    Hosoyama, Toru
    Enoki, Tadahiko
    Li, Tao-Sheng
    Hamano, Kimikazu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 438 (03) : 513 - 518
  • [7] Discovery of novel STAT3 DNA binding domain inhibitors
    Wu, Bocheng
    Payero, Benny
    Taylor, Sydney
    Oyelere, Adegboyega K.
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (15) : 1253 - 1269
  • [8] Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo
    W Huang
    Z Dong
    Y Chen
    F Wang
    C J Wang
    H Peng
    Y He
    G Hangoc
    K Pollok
    G Sandusky
    X-Y Fu
    H E Broxmeyer
    Z-Y Zhang
    J-Y Liu
    J-T Zhang
    Oncogene, 2016, 35 : 783 - 792
  • [9] Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
    Yoshiyuki Minegishi
    Masako Saito
    Shigeru Tsuchiya
    Ikuya Tsuge
    Hidetoshi Takada
    Toshiro Hara
    Nobuaki Kawamura
    Tadashi Ariga
    Srdjan Pasic
    Oliver Stojkovic
    Ayse Metin
    Hajime Karasuyama
    Nature, 2007, 448 : 1058 - 1062
  • [10] Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
    Minegishi, Yoshiyuki
    Saito, Masako
    Tsuchiya, Shigeru
    Tsuge, Ikuya
    Takada, Hidetoshi
    Hara, Toshiro
    Kawamura, Nobuaki
    Ariga, Tadashi
    Pasic, Srdjan
    Stojkovic, Oliver
    Metin, Ayse
    Karasuyama, Hajime
    NATURE, 2007, 448 (7157) : 1058 - U10